Table 1.
H2S Donor | Mechanism of Action | Disease Models | Effects on Cells | References |
---|---|---|---|---|
S-propargyl-cysteine (SPRC) | Ameliorates Nrf2-ARE pathway | In rheumatoid arthritis | Anti-inflammatory | [31] |
Suppression of pro-inflammatory cytokines | In pancreatitis-induced acute lung injury | Anti-inflammatory | [32] | |
Decreases the ROS formation, Bax caspase 3 and 9, increase Bcl-2 expression | Myocardial infarction and heart failure | Antioxidant Promotes angiogenesis |
[33] | |
Morpholin-4-ium 4-methoxyphenyl-morp holino-phosphinodithioate (GYY4137) |
Inhibition of P13/Akt/TLR4 pathway | Atherosclerosis | Maintain mitochondrial function | [34] |
Suppression of pro-inflammatory cytokines and chemokines | RSV-infected cells | Anti-inflammatory | [35] | |
Activation of Nrf2-ARE pathway and suppression of NOS2 and COX-2 expression. | In osteoarthritis | Antioxidant | [36] | |
Decreased upregulation of iNOS, COX2, NF-кB, and STAT 3 | Endotoxemia | Anti-inflammatory | [37] | |
Increased TGF-β expression and decreased IFN-γ and IL-17 production | Multiple sclerosis | Anti-inflammatory | [38] | |
AP-39 | Modulation of AMPK/UCP2 pathway and decrease in ROS | Ischemia–reperfusion injury and cardiotoxicity | Antioxidant Maintain mitochondrial function |
[39] |
Decrease in MPO and IL-6 levels, increase in IL-10 levels | Acute lung injury | Anti-inflammatory | [40] | |
Allicin and Diallyl disulfide (DADS) | Activates Nrf2/ARE pathway | Cardiac hypertrophy and Alzheimer’s disease | Antioxidant | [41,42,43] |
Inhibition of pro-inflammatory cytokines | In viral-associated lung injury | Anti-inflammatory | [44] | |
Suppression of p-AKT, NOS2, and PI3K levels | In osteoarthritis | Mitigate pain | [45] | |
S-diclofenac | Suppression of NF-κB pathway | Pancreatic and acute lung injury in acute pancreatitis | Anti-inflammatory | [46] |
Stabilizes P53, P21, P53AIPI, and Bax | Atherosclerosis | Antiproliferative | [36] | |
Inhibition of COX enzymes, NO production, and decreased MPO activity | Carrageenan induced hind-paw edema | Anti-inflammatory | [47] | |
NaHS | Activation of ERK and NF-κB signaling pathways | Sepsis-induced organ damage | Pro-inflammatory | [48] |
Activation of NF-κB and Src-family kinase signaling pathways | Acute pancreatitis | Pro-inflammatory | [49] | |
Activation of cGMP/PKG signaling pathway | Myocardial infarction | Antioxidant | [50] | |
Inhibition of mitochondrial transmembrane potential loss | Parkinson’s disease | Relieve mitochondrial dysfunction | [51] | |
Inhibits IkB-a degradation and NF-κB nuclear translocation |
Atherosclerosis | Decreases expression of adhesion molecules (specifically ICAM-1) | [52] |